hyaluronidase

Generic: hyaluronidase

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name hyaluronidase
Generic Name hyaluronidase
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

hyaluronidase (human recombinant) 150 [USP'U]/mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1555
Product ID 51662-1555_c3f1db01-58c0-2226-e053-2a95a90a8b33
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA021859
Listing Expiration 2026-12-31
Marketing Start 2021-06-04

Pharmacologic Class

Established (EPC)
endoglycosidase [epc]
Chemical Structure
glycoside hydrolases [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621555
Hyphenated Format 51662-1555

Supplemental Identifiers

RxCUI
630936 630939
UNII
743QUY4VD8
NUI
N0000175531 M0009499

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name hyaluronidase (source: ndc)
Generic Name hyaluronidase (source: ndc)
Application Number BLA021859 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 150 [USP'U]/mL
source: ndc
Packaging
  • 1 VIAL in 1 BOX (51662-1555-1) / 1 mL in 1 VIAL
source: ndc

Packages (1)

51662-1555-1 1 VIAL in 1 BOX (51662-1555-1) / 1 mL in 1 VIAL

Ingredients (1)

hyaluronidase (human recombinant) (150 [USP'U]/mL)

Linked Drug Pages (1)

HYALURONIDASE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "c3f1db01-58c0-2226-e053-2a95a90a8b33", "openfda": {"nui": ["N0000175531", "M0009499"], "unii": ["743QUY4VD8"], "rxcui": ["630936", "630939"], "spl_set_id": ["c3f1db01-58bf-2226-e053-2a95a90a8b33"], "pharm_class_cs": ["Glycoside Hydrolases [CS]"], "pharm_class_epc": ["Endoglycosidase [EPC]"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 BOX (51662-1555-1)  / 1 mL in 1 VIAL", "package_ndc": "51662-1555-1", "marketing_start_date": "20210604"}], "brand_name": "HYALURONIDASE", "product_id": "51662-1555_c3f1db01-58c0-2226-e053-2a95a90a8b33", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Endoglycosidase [EPC]", "Glycoside Hydrolases [CS]"], "product_ndc": "51662-1555", "generic_name": "HYALURONIDASE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "HYALURONIDASE", "active_ingredients": [{"name": "HYALURONIDASE (HUMAN RECOMBINANT)", "strength": "150 [USP'U]/mL"}], "application_number": "BLA021859", "marketing_category": "BLA", "marketing_start_date": "20210604", "listing_expiration_date": "20261231"}